Patent · US Active

Glycosaminoglycans from Alligator mississippiensis

US11224612B1 · kind B1 · utility

0Cited by

1References

5Claims

0Family size

Assignee

BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE · US

Inventors

Jack N. Losso · Baton Rouge, US
Jose Daniel Estrada Andino · Minneapolis, US

Key dates

Filing date	Jul 10, 2019
Grant date	Jan 18, 2022
Priority date	—
Expiry date	Aug 3, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K35/58
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Glycosaminoglycans, particularly hyaluronic acid, are extracted from alligator carcasses, feet, backstraps, and eyeballs. The alligator-derived glycosaminoglycans can be used in treatments for cystic fibrosis (CF), in treating other inflammatory conditions, and for other purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.